Clinical Trials Browser

Phase 1 × Thyroid Carcinoma, Anaplastic × Radiotherapy, Intensity-Modulated × Clear all

NCT03975231 2026-04-08

Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer

Phase 1 Recruiting

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic